We’re five years in, so what does the CBD industry look like now and what can we expect in 2023? We spoke with several CBD experts who walked us through the highs and lows of 2022.
Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...
Canada-based Willow Biosciences Inc. has announced it will soon start to deliver its first samples of “ultra-pure, pharmaceutical grade” cannabigerol (CBG) from its 500-liter pilot production run.
Fermentation: A pathway to 'superior cannabinoids at significantly reduced cost'?
CBD (cannabidiol) produced via fermentation could hit the market early next year following a partnership between synthetic biology expert Amyris, and LAVVAN, Inc., a newly-formed company committed to “providing the market with superior cannabinoids at...